ONCAlert | Upfront Therapy for mRCC
News
Expert Highlights Data that Led to the Approval of Fedratinib in Myelofibrosis
8:34 PM, Thu August 22, 2019
Selinexor Induces Meaningful Survival in Heavily Pretreated Multiple Myeloma in STORM Trial
5:08 PM, Thu August 22, 2019
FDA Grants Priority Review to Zanubrutinib for Previously Treated Mantle Cell Lymphoma
1:49 PM, Thu August 22, 2019
Shared Decision Making With Patients Could Prevent RAI Overtreatment in Thyroid Cancer, Study Suggests
1:30 PM, Thu August 22, 2019
FDA Grants Priority Review to Enzalutamide for Metastatic Hormone-Sensitive Prostate Cancer
7:10 PM, Wed August 21, 2019
Precision Medicine Trials and Molecular Testing Guidelines Expand to Reach More Patients
6:17 PM, Wed August 21, 2019
OS Results Fall Flat With Durvalumab/Tremelimumab Combo in NEPTUNE Trial
2:57 PM, Wed August 21, 2019
Expert Says Talazoparib Plus Enzalutamide May Change the Standard of Care for Prostate Cancer
4:00 PM, Tue August 20, 2019
